Abstract:Introduction: Although chronic subdural hematoma (CSDH) is a common neurosurgical disease, there is a lack of algorithms for the treatment of asymptomatic and symptomatic CSDH. The purpose of this article is to describe an algorithm developed using our institutional experience for the treatment of symptomatic CSDH that aims to decrease symptoms and/or hematoma size or to completely resolve both. Our algorithm for treatment of symptomatic CSDH includes subdural drain (SDD) placement via twist-drill craniostomy (TDC) as the first-line treatment, followed by supplemental tissue plasminogen activator (tPA) as second-line treatment, with possible middle meningeal artery embolization (MMAE), followed by craniotomy as the last therapeutic option. This study investigated the efficacy of our institution's algorithm in treating symptomatic CSDH. Methods: A retrospective study was conducted from 2019 to 2023 identifying patients with CSDH treated with TDC. Electronic medical records were used to gather patient demographics, clinical presentation, radiographic findings, treatment modalities, and clinical outcomes. Results: There were a total of 109 patients with 128 SDD placements. All 109 patients underwent TDC; among them, 37 patients received tPA instillation with three patients requiring craniotomy. Factors including age, gender, race, mechanism of injury, blood thinner usage, Glasgow Coma Scale (GCS), neurologic exam, thickness of CSDH, and midline shift were comparable for all patients regardless of treatment received. The mean number of neomembranes was higher in patients who eventually required craniotomy (4.5) compared to those treated with TDC only (1.8) and TDC+tPA (2.1) (p=0.0035). There was a greater mean hematoma drainage in patients who received tPA instillation without craniotomy (586.7 mL) than those treated with TDC only (293.0 mL) (p<0.0001). Clinical improvement was found in 52/72 patients (72.2%) treated with TDC only, 23/34 patients (67.6%) treated with TDC+tPA only, and 0/3 patients (0.0%) treated with TDC+tPA+craniotomy. Radiographic improvement in mean thickness of CSDH and midline shift, respectively, was found in patients treated with TDC only (p<0.0001; p<0.0001) and TDC+tPA (p<0.0001; p<0.0001) but not in TDC+tPA+craniotomy (p=0.1494; p=0.0762). There were also fewer neomembranes after TDC+tPA treatment only (2.1 vs. 0.5, p<0.0001). Seven patients were readmitted that did not follow the algorithm and only patients treated following the algorithm showed clinical and radiographic improvement. Conclusions: Using our institutional algorithm, our study demonstrates successful clinical outcomes in treating symptomatic CSDH and recurrent CSDH with minimally invasive therapeutic interventions including SDD via TDC and tPA, thereby minimizing the utilization of more invasive interventions including craniotomy.

Spontaneous Resolution of Nontraumatic Chronic Subdural Hematoma Associated with Anti-Aggregation Therapy

Spontaneous Rapid Resolution of Acute Subdural Hematoma after Head Trauma: is It Truly Rare?

Double-loculated Calcification Chronic Subdural Hematoma

Clinical characteristics of 15 cases of chronic subdural hematomas due to spontaneous intracranial hypotension with spinal cerebrospinal fluid leak

[A resolving sign of acute subdural hematoma: from report of two cases]

A Case of Spontaneous Atraumatic Subdural Hematoma Without Known Precipitating Factors

Rapid Resolution of Subdural Hematoma after Targeted Epidural Blood Patch Treatment in Patients with Spontaneous Intracranial Hypotension.

Spontaneous Thoracic Ventral Spinal Subdural Hematoma Mimicking a Tumoral Lesion: a Case Report

Management of Spontaneous Cerebrospinal Fluid Hypovolemia-Associated Massive Chronic Subdural Hematoma with Reinforced Restriction of Physical Activity: Report of Three Cases.

Management of spontaneous intracranial hypotension with subdural hematoma: Report of 2 cases

Spontaneous Spinal Subdural Hematoma: Case Report of 2 Years' Clinical and Radiologic Findings

Expert consensus on drug treatment of chronic subdural hematoma

Spontaneous Intracranial Hypotension Following Epidural Anesthesia: a Case Report

Thrombolytic Therapy as a Superior Option: Insights from Three Cases of Acute Subdural Hematoma Following Surgery for Chronic Subdural Hematoma

Rapid Spontaneously Resolving Acute Subdural Hematoma.

Chronic Subdural Hematomas—A Retrospective Analysis of the Internal Architecture and Evaluation of Risk Factors for Recurrences After Surgical Therapy

An Algorithm for Treatment of Symptomatic Chronic Subdural Hematomas

Chronic Subdural Haematoma Evolving from Traumatic Subdural Hydroma.

Chronic subdural haematoma in antithrombotic cohorts: characteristics, surgical outcomes, and recurrence

Understanding Chronic Subdural Hematoma: Pathophysiology

Spontaneous chronic subdural hematoma development in chronic myeloid leukemia cases at remission phase under maintenance therapy, management strategy - a series with literature review